Emerging and neglected tropical diseases: Translational application of proteomics

Experimental Biology and Medicine

Volumn 236, Issue 8, 2011, Pages 972-976

  Denman, Britta ^a,b   Goodman, Steven R ^a,b  

^a Department of Medicine ^*  (United States)

^b SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

Author keywords

Biodefense; Bioterrorism; Emerging diseases; Infectious disease; Outbreaks; Pathogen discovery; Proteomics; Vaccine development

Indexed keywords

AEDES AEGYPTI; BACILLUS ANTHRACIS; BRUGIA MALAYI; CELL INTERACTION; CEREBROSPINAL FLUID; CHAGAS DISEASE; CHIKUNGUNYA; CHLAMYDIAL PNEUMONIA; DENGUE; DISEASE CONTROL; FRANCISELLA TULARENSIS; HAEMOPHILUS INFLUENZAE; JAPANESE ENCEPHALITIS; LEISHMANIASIS; LEPROSY; LEPTOSPIROSIS; LYMPHATIC FILARIASIS; MASS SPECTROMETRY; NEGLECTED DISEASE; NEISSERIA MENINGITIDIS; NEMATODIASIS; NONHUMAN; ONCHOCERCIASIS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN EXPRESSION; PROTEOMICS; REVIEW; SCHISTOSOMA JAPONICUM; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; SEVERE ACUTE RESPIRATORY SYNDROME; STREPTOCOCCUS AGALACTIAE; TROPICAL DISEASE; VACCINE PRODUCTION;

COMMUNICABLE DISEASES, EMERGING; HOST-PATHOGEN INTERACTIONS; HUMANS; NEGLECTED DISEASES; PARASITIC DISEASES; PROTEOMICS; PUBLIC HEALTH; TROPICAL MEDICINE;

EID: 79961178546     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1258/ebm.2011.011067     Document Type: Review

References (78)

1. Cutler SJ, Fooks AR, Van der Poel WH. Public health threat of new, reemerging, and neglected zoonoses in the industrialized world. Emerg Infect Dis 2010;16:1-7
2. Reperant LA. Applying the theory of island biogeography to emerging pathogens: toward predicting the sources of future emerging zoonotic and vector-borne diseases. Vector Borne Zoonotic Dis 2010;10:105-10
3. Woolhouse ME, Gowtage-Sequeria S. Host range and emerging and reemerging pathogens. Emerg Infect Dis 2005;11:1842-7
4. Bengis RG, Leighton FA, Fischer JR, Artois M, Morner T, Tate CM. The role of wildlife in emerging and re-emerging zoonoses. Rev Sci Technol 2004;23:497-511
5. Daszak P, Cunningham AA, Hyatt AD. Anthropogenic environmental change and the emergence of infectious diseases in wildlife. Acta Trop 2001;78:103-16
6. Jones KE, Patel NG, Levy MA, Storeygard A, Balk D, Gittleman JL, Dazak P. Global trends in emerging infectious diseases. Nature 2008;451:990-3
7. Neglected tropical diseases, hidden successes, emerging opportunities. WHO/HTM/NTD/2009.2, 2009. See http://whqlibdoc.who.int/publications/2009/9789241598705_eng.pdf (last checked 9 June 2011)
8. Hotez PJ, Kamath A. Neglected tropical diseases in sub-saharan Africa: review of their prevalence, distribution, and disease burden. PLoS Negl Trop Dis 2009;3:e412
9. Mathers CD, Ezzati M, Lopez AD. Measuring the burden of neglected tropical diseases: the global burden of disease framework. PLoS Negl Trop Dis 2007;1:e114
10. Hotez PJ, Thompson TG. Waging peace through neglected tropical disease control: a US foreign policy for the bottom billion. PLoS Negl Trop Dis 2009;3:e346
11. Hosseini P, Sokolow SH, Vandegrift KJ, Kilpatrick AM, Daszak P. Predictive power of air travel and socio-economic data for early pandemic spread. PLoS One 2010;5:e12763
12. Graham DR, Elliott ST, Van Eyk JE. Broad-based proteomic strategies: a practical guide to proteomics and functional screening. J Physiol 2005;563(Part 1):1-9
13. Liotta LA, Petricoin EF. Mass spectrometry-based protein biomarker discovery: solving the remaining challenges to reach the promise of clinical benefit. Clin Chem 2010;56:1641-2
14. Tambor V, Fucíková A, Lenco J, Kacerovský M, Rehácek V, Stulík J, Pudil R. Application of proteomics in biomarker discovery: a primer for the clinician. Physiol Res 2010;59:471-9
15. Figeys D. Functional proteomics: mapping protein-protein interactions and pathways. Curr Opin Mol Ther 2002;4:210-5
16. Ye Y, Mar EC, Tong S, Sammons S, Fang S, Anderson LJ, Wang D. Application of proteomics methods for pathogen discovery. J Virol Methods 2010;163:87-95
17. Okamoto K, Endo Y, Inoue S, Nabeshima T, Nga PT, Guillermo PH, Yu F, Loan do P, Trang BM, Natividad FF, Hasebe F, Morita K. Development of a rapid and comprehensive proteomics-based arboviruses detection system. J Virol Methods 2010;167:31-6
18. Dupuis A, Hennekinne JA, Garin J, Brun V. Protein Standard Absolute Quantification (PSAQ) for improved investigation of staphylococcal food poisoning outbreaks. Proteomics 2008;8:4633-6
19. Hennekinne JA, Brun V, De Buyser ML, Dupuis A, Ostyn A, Dragacci S. Innovative application of mass spectrometry for the characterization of staphylococcal enterotoxins involved in food poisoning outbreaks. Appl Environ Microbiol 2009;75:882-4
20. Mazzulli T, Low DE, Poutanen SM. Proteomics and severe acute respiratory syndrome (SARS): emerging technology meets emerging pathogen. Clin Chem 2005;51:67
21. Bartlam M, Xu Y, Rao Z. Structural proteomics of the SARS coronavirus: a model response to emerging infectious diseases. J Struct Funct Genomics 2007;8:85-97
22. Canard B, Joseph JS, Kuhn P. International research networks in viral structural proteomics: again, lessons from SARS. Antiviral Res 2008;78:47-50
23. Kang X, Xu Y, Wu X, Liang Y, Wang C, Guo J, Wang Y, Chen M, Wu D, Wang Y, Bi S, Qiu Y, Lu P, Cheng J, Xiao B, Hu L, Gao X, Liu J, Wang Y, Song Y, Zhang L, Suo F, Chen T, Huang Z, Zhao Y, Lu H, Pan C, Tang H. Proteomic fingerprints for potential application to early diagnosis of severe acute respiratory syndrome. Clin Chem 2005;51:56-64
24. Yip TT, Cho WC, Cheng WW, Chan JW, Ma VW, Yip TT, Lau Yip CN, Ngan RK, Law SC. Application of ProteinChip array profiling in serum biomarker discovery for patients suffering from severe acute respiratory syndrome. Methods Mol Biol 2007;382:313-31
25. Pang RT, Poon TC, Chan KC, Lee NL, Chiu RW, Tong YK, Wong RM, Chim SS, Ngai SM, Sung JJ, Lo YM. Serum proteomic fingerprints of adult patients with severe acute respiratory syndrome. Clin Chem 2006;52:421-9
26. Poon TC, Pang RT, Chan KC, Lee NL, Chiu RW, Tong YK, Chim SS, Ngai SM, Sung JJ, Lo YM. Proteomic profiling in SARS: diagnostic and prognostic applications. Hong Kong Med J 2009;15 (Suppl. 8):15-8
27. Nicoll A, Ammon A, Amato Gauci A, Ciancio B, Zucs P, Devaux I, Plata F, Mazick A, Mølbak K, Asikainen T, Kramarz P. Experience and lessons from surveillance and studies of the 2009 pandemic in Europe. Public Health 2010;124:14-23
28. Miotto O, Heiny AT, Albrecht R, García-Sastre A, Tan TW, August JT, Brusic V. Complete proteome mapping of human influenza A adaptive mutations: implications for human transmissibility of zoonotic strains. PLoS One 2010;5:e9025
29. Morrissey B, Downard KM. A proteomics approach to survey the antigenicity of the influenza virus by mass spectrometry. Proteomics 2006;6:2034-41
30. Xu L, Bao L, Lv Q, Deng W, Ma Y, Li F, Zhan L, Zhu H, Ma C, Qin C. A single-amino-acid substitution in the HA protein changes the replication and pathogenicity of the 2009 pandemic A (H1N1) influenza viruses in vitro and in vivo. Virol J 2010;7:325
31. Drake RR, Deng Y, Schwegler EE, Gravenstein S. Proteomics for biodefense applications: progress and opportunities. Expert Rev Proteomics 2005;2:203-13
32. Park SH, Oh HB, Seong WK, Kim CW, Cho SY, Yoo CK. Differential analysis of Bacillus anthracis after pX01 plasmid curing and comprehensive data on Bacillus anthracis infection in macrophages and glial cells. Proteomics 2007;7:3743-58
33. Pavkova I, Reichelova M, Larsson P, Hubalek M, Vackova J, Forsberg A, Stulik J. Comparative proteome analysis of fractions enriched for membrane associated proteins from Francisella tularensis subsp. tularensis and F. tularensis subsp. holarctica strains. J Proteome Res 2006;5:3125-34
34. Tchankouo-Nguetcheu S, Khun H, Pincet L, Roux P, Bahut M, Huerre M, Guette C, Choumet V. Differential protein modulation in midguts of Aedes aegypti infected with chikungunya and dengue 2 viruses. PLoS One 2010;5
35. Sirot LK, Poulson RL, McKenna MC, Girnary H, Wolfner MF, Harrington LC. Identity and transfer of male reproductive gland proteins of the dengue vector mosquito, Aedes aegypti: potential tools for control of female feeding and reproduction. Insect Biochem Mol Biol 2008;38:176-89
36. Levett PN. Leptospirosis. Clin Microbiol Rev 2001;14:296-326
37. Malmstrom J, Beck M, Schmidt A, Lange V, Deutsch EW, Aebersold R. Proteome-wide cellular protein concentrations of the human pathogen Leptospira interrogans. Nature 2009;460:762-5
38. Vieira ML, Pimenta DC, de Morais ZM, Vasconcellos SA, Nascimento AL. Proteome analysis of Leptospira interrogans virulent strain. Open Microbiol J 2009;3:69-74
39. Eshghi A, Cullen PA, Cowen L, Zuerner RL, Cameron CE. Global proteome analysis of Leptospira interrogans. J Proteome Res 2009;8:4564-78
40. Sakolvaree Y, Maneewatch S, Jiemsup S, Klaysing B, Tongtawe P, Srimanote P, Saengjaruk P, Banyen S, Tapchaisri P, Chonsa-nguan M, Chaicumpa W. Proteome and immunome of pathogenic Leptospira spp. revealed by 2DE and 2DE-immunoblotting with immune serum. Asian Pac J Allergy Immunol 2007;25:53-73
41. Thongboonkerd V. Proteomics in leptospirosis research: towards molecular diagnostics and vaccine development. Expert Rev Mol Diagn 2008;8:53-61
42. Thongboonkerd V, Chiangjong W, Saetun P, Sinchaikul S, Chen ST, Kositanont U. Analysis of differential proteomes in pathogenic and nonpathogenic Leptospira: potential pathogenic and virulence factors. Proteomics 2009;9:3522-34
43. Mandell GL, Gordon R, Bennett JE. Principles and Practice of Infectious Diseases. Vol. 7. Edn 2009, Philadelphia: Churchill Livingstone, 2009
44. Chuan J, Feng Z, Brindley PJ, McManus DP, Han Z, Jianxin P, Hu W. Our wormy world genomics, proteomics and transcriptomics in East and southeast Asia. Adv Parasitol 2010;73:327-71
45. Brindley PJ, Mitreva M, Ghedin E, Lustigman S. Helminth genomics: the implications for human health. PLoS Negl Trop Dis 2009;3:e538
46. Mushahwar IK. Hepatitis E virus: molecular virology, clinical features, diagnosis, transmission, epidemiology, and prevention. J Med Virol 2008;80:646-58
47. Teshale EH, Hu DJ, Holmberg SD. The two faces of hepatitis E virus. Clin Infect Dis 2010;51:328-34
48. Dalton HR, Bendall R, Ijaz S, Banks M. Hepatitis E: an emerging infection in developed countries. Lancet Infect Dis 2008;8:698-709
49. Khuroo MS, Teli MR, Skidmore S, Sofi MA, Khuroo MI. Incidence and severity of viral hepatitis in pregnancy. Am J Med 1981;70:252-5
50. Taneja S, Sen S, Gupta VK, Aggarwal R, Jameel S. Plasma and urine biomarkers in acute viral hepatitis E. Proteome Sci 2009;7:39
51. Bambini S, Rappuoli R. The use of genomics in microbial vaccine development. Drug Discov Today 2009;14:252-60
52. Poland GA, Ovsyannikova IG, Jacobson RM. Personalized vaccines: the emerging field of vaccinomics. Expert Opin Biol Ther 2008; 8:1659-67
53. Poland GA, Ovsyannikova IG, Jacobson RM. Application of pharmacogenomics to vaccines. Pharmacogenomics 2009;10:837-52
54. Poland GA, Jacobson RM, Ovsyannikova IG. Trends affecting the future of vaccine development and delivery: the role of demographics, regulatory science, the anti-vaccine movement, and vaccinomics. Vaccine 2009;27:3240-4
55. Viswanathan K, Fruh K. Viral proteomics: global evaluation of viruses and their interaction with the host. Expert Rev Proteomics 2007;4:815-29
56. Maxwell KL, Frappier L. Viral proteomics. Microbiol Mol Biol Rev 2007;71:398-411
57. Manes NP, Estep RD, Mottaz HM, Moore RJ, Clauss TR, Monroe ME, Du X, Adkins JN, Wong SW, Smith RD. Comparative proteomics of human monkeypox and vaccinia intracellular mature and extracellular enveloped virions. J Proteome Res 2008;7:960-8
58. Van Vliet K, Mohamed MR, Zhang L, Villa NY, Werden SJ, Liu J, McFadden G. Poxvirus proteomics and virus-host protein interactions. Microbiol Mol Biol Rev 2009;73:730-49
59. Van Duyne R, Kehn-Hall K, Klase Z, Easley R, Heydarian M, Saifuddin M, Wu W, Kashanchi F. Retroviral proteomics and interactomes: intricate balances of cell survival and viral replication. Expert Rev Proteomics 2008;5:507-28
60. Seib KL, Dougan G, Rappuoli R. The key role of genomics in modern vaccine and drug design for emerging infectious diseases. PLoS Genet 2009;5:e1000612
61. Grandi G. Rational antibacterial vaccine design through genomic technologies. Int J Parasitol 2003;33:615-20
62. Grandi G. Antibacterial vaccine design using genomics and proteomics. Trends Biotechnol 2001;19:181-8
63. Walters MS, Mobley HL. Bacterial proteomics and identification of potential vaccine targets. Expert Rev Proteomics 2010;7:181-4
64. Moxon R, Rappuoli R. Bacterial pathogen genomics and vaccines. Br Med Bull 2002;62:45-58
65. Serruto D, Adu-Bobie J, Capecchi B, Rappuoli R, Pizza M, Masignani V. Biotechnology and vaccines: application of functional genomics to Neisseria meningitidis and other bacterial pathogens. J Biotechnol 2004;113:15-32
66. Sette A, Rappuoli R. Reverse vaccinology: developing vaccines in the era of genomics. Immunity 2010;33:530-41
67. Kaushik DK, Sehgal D. Developing antibacterial vaccines in genomics and proteomics era. Scand J Immunol 2008;67:544-52
68. Meinke A, Henics T, Nagy E. Bacterial genomes pave the way to novel vaccines. Curr Opin Microbiol 2004;7:314-20
69. Scarselli M, Giuliani MM, Adu-Bobie J, Pizza M, Rappuoli R. The impact of genomics on vaccine design. Trends Biotechnol 2005;23:84-91
70. Capecchi B, Serruto D, Adu-Bobie J, Rappuoli R, Pizza M. The genome revolution in vaccine research. Curr Issues Mol Biol 2004;6:17-27
71. Doytchinova IA, Taylor P, Flower DR. Proteomics in vaccinology and immunobiology: an informatics perspective of the immunone. J Biomed Biotechnol 2003;2003:267-90
72. Dijkshoorn L, De Vos P, Dedeurwaerdere T. Understanding patterns of use and scientific opportunities in the emerging global microbial commons. Res Microbiol 2010;161:407-13
73. Bexfield N, Kellam P. Metagenomics and the molecular identification of novel viruses. Vet J 2010 [Epub ahead of print]. DOI: 10.1016/ j.tvjl.2010.10.014
74. Svraka S, Rosario K, Duizer E, van der Avoort H, Breitbart M, Koopmans M. Metagenomic sequencing for virus identification in a public-health setting. J Gen Virol 2010;91(Part 11):2846-56
75. Greninger AL, Chen EC, Sittler T, Scheinerman A, Roubinian N, Yu G, Kim E, Pillai DR, Guyard C, Mazzulli T, Isa P, Arias CF, Hackett J, Schochetman G, Miller S, Tang P, Chiu CY. A metagenomic analysis of pandemic influenza A (2009 H1N1) infection in patients from North America. PLoS One 2010;5:e13381
76. Verberkmoes NC, Russell AL, Shah M, Godzik A, Rosenquist M, Halfvarson J, Lefsrud MG, Apajalahti J, Tysk C, Hettich RL, Jansson JK. Shotgun metaproteomics of the human distal gut microbiota. ISME J 2009;3:179-89
77. Rudney JD, Xie H, Rhodus NL, Ondrey FG, Griffin TJ. A metaproteomic analysis of the human salivary microbiota by three-dimensional peptide fractionation and tandem mass spectrometry. Mol Oral Microbiol 2010;25:38-49
78. National Institute of Allergy and Infectious Disease (NIAID). List of NIAID Emerging and Re-emerging Diseases [updated 20 December 2010]. See http://www.niaid.nih.gov/topics/emerging/pages/list.aspx (last checked 27 April 2011)